Diseases of the Abdomen and Pelvis 2018-2021 : : Diagnostic Imaging - IDKD Book.
Saved in:
Superior document: | IDKD Springer Series |
---|---|
: | |
TeilnehmendeR: | |
Place / Publishing House: | Cham : : Springer International Publishing AG,, 2018. ©2018. |
Year of Publication: | 2018 |
Edition: | 1st ed. |
Language: | English |
Series: | IDKD Springer Series
|
Online Access: | |
Physical Description: | 1 online resource (262 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Intro
- Contents
- 1: Renal Tumors
- 1.1 Introduction
- 1.2 Modalities for Imaging Renal Masses
- 1.2.1 Ultrasound
- 1.2.2 CT and MRI
- 1.3 Very Small Renal Masses (<
- 1-1.5 cm)
- 1.4 Cystic Renal Masses
- 1.5 Angiomyolipomas (AMLs)
- 1.6 Other Solid Renal Masses
- 1.6.1 Oncocytomas
- 1.6.2 Renal Cancers
- 1.6.2.1 Clear Cell Renal Cancer
- 1.6.2.2 Papillary Renal Cancer
- 1.6.2.3 Chromophobe Renal Cancer
- 1.6.2.4 Uncommon Renal Cancer Cell Types
- 1.6.3 Urothelial Neoplasms, Lymphoma, and Renal Artery Aneurysms
- 1.7 Solid Renal Mass Growth Rates
- 1.8 Radiomics
- 1.9 Use of Imaging for Solid Renal Mass Differentiation
- 1.10 Percutaneous Biopsy of Renal Masses
- 1.11 Pretreatment Assessment of Renal Cancer
- 1.11.1 Staging
- 1.11.2 RENAL Nephrometry
- 1.12 Renal Cancer Management
- 1.13 Imaging After Renal Cancer Treatment
- 1.13.1 After Renal Mass Ablation or Resection
- 1.13.2 Imaging After Partial or Total Nephrectomy
- 1.13.3 Imaging After Treatment of Metastatic Disease
- 1.13.3.1 RECIST
- 1.13.3.2 Multikinase Inhibitors
- 1.13.3.3 Immunotherapy
- 1.13.3.4 Complications of Multikinase Inhibitor Treatment and Immunotherapy
- 1.14 Concluding Remarks
- References
- 2: MRI of the Pelvic Floor and MR Defecography
- 2.1 Introduction
- 2.2 Functional Anatomy of the Pelvic Floor
- 2.2.1 Pathogenesis
- 2.2.2 Levator Ani Muscle (LAM)
- 2.2.3 Endopelvic Fascia
- 2.2.3.1 Pubocervical Fascia
- 2.2.3.2 Rectovaginal Fascia
- 2.2.4 Etiology of Pelvic Floor Failure
- 2.2.5 Indication for Dynamic Pelvic Floor Imaging
- 2.3 Diagnosis of PFD Using Dynamic MRI
- 2.3.1 General Preparation
- 2.3.2 DPF-MRI Procedure
- 2.3.2.1 Patients' Positioning and Preparation
- 2.3.2.2 MRI Sequences
- 2.3.3 MRI Interpretation
- 2.3.3.1 Measurement and Grading.
- 2.3.3.2 Further Evaluation
- 2.4 Overview on Compartment-Based Symptoms
- 2.4.1 Anterior Compartment
- 2.4.2 Middle Compartment
- 2.4.3 Posterior Compartment
- 2.5 Concluding Remarks
- References
- 3: Benign Disease of the Uterus
- 3.1 Introduction
- 3.2 Normal Anatomy of the Uterus
- 3.3 MRI Technique
- 3.4 Congenital Anomalies
- 3.4.1 Class 0 (Normal Uterus)
- 3.4.2 Class U1 (Dysmorphic Uterus)
- 3.4.3 Class U2 (Septate Uterus) (Fig. 3.4)
- 3.4.4 Class U3 (Bicorporeal Uterus, syn: Bicornuate Uterus) (Fig. 3.5)
- 3.4.5 Class U4 (Hemi-uterus) (Fig. 3.6)
- 3.4.6 Class U5 (Aplastic Uterus)
- 3.4.7 Class U6 (Unclassified Cases)
- 3.4.8 Classification of Congenital Anomalies of the Cervix and the Vagina
- 3.5 Leiomyoma (Figs. 3.7 and 3.8)
- 3.6 Adenomyosis (Fig. 3.9)
- 3.7 Myometrial Contractions
- 3.8 Endometrial Pathology
- 3.9 Benign Pathology of the Cervix and Vagina
- 3.10 Deep Endometriosis
- 3.11 Concluding Remarks
- References
- 4: Therapy Monitoring of Oncologic Disease in the Abdomen (Including PET/CT)
- 4.1 Introduction
- 4.2 Assessment of Local Response to Neoadjuvant Treatment in Rectal Cancer
- 4.2.1 Selection of Patients for Neoadjuvant Therapy
- 4.2.2 Assessment of Local Tumor Response and Resectability
- 4.2.3 Assessment of Complete Response After Chemoradiotherapy
- 4.2.4 Assessment of Response for Nodal Disease
- 4.3 Assessment of Response for Systemic Disease
- 4.3.1 Response Based on Morphology for Chemotherapy
- 4.3.2 Response Based on Morphology for Immunotherapy
- 4.3.3 Response Based on FDG PET
- 4.4 Monitoring GIST Molecular Targeted Systemic Therapy
- 4.4.1 Monitoring GIST with CT/MRI
- 4.4.2 Monitoring GIST with PET
- 4.5 Monitoring Liver Disease After SIRT
- 4.5.1 Monitoring SIRT with CT/MRI
- 4.5.2 Monitoring SIRT with PET.
- 4.6 Monitoring Neuroendocrine Tumors
- 4.7 Monitoring Metastasized Prostate Cancer (I)
- 4.7.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans
- 4.7.2 Monitoring Metastasized Prostate Cancer with MRI and PET/CT
- References
- 5: Disease of the Gallbladder and Biliary Tree
- 5.1 Biliary Tract
- 5.1.1 Congenital Biliary Anomalies
- 5.1.1.1 Choledochal Cyst
- 5.1.2 Choledocholithiasis
- 5.1.3 Inflammatory Disorders (Cholangitis)
- 5.1.3.1 Suppurative Cholangitis
- 5.1.3.2 Recurrent Pyogenic Cholangitis
- 5.1.3.3 Primary Sclerosing Cholangitis
- 5.1.3.4 IgG4-Related Cholangitis
- 5.1.4 Neoplasms
- 5.1.4.1 Benign Tumors of the Bile Ducts
- Biliary Hamartoma
- Biliary Cystadenoma (Biliary Mucinous Cystic Neoplasms)
- Intraductal Papillary Neoplasm of the Bile Duct (IPNB)
- 5.1.4.2 Malignant Tumors of the Bile Ducts
- 5.2 Gallbladder
- 5.2.1 Normal Anatomy
- 5.2.2 Congenital Variants and Anomalies
- 5.2.2.1 Agenesis of the Gallbladder
- 5.2.2.2 Duplication of the Gallbladder
- 5.2.2.3 Phrygian Cap of the Gallbladder
- 5.2.2.4 Multiseptate Gallbladder
- 5.2.2.5 Diverticula of the Gallbladder
- 5.2.2.6 Ectopic Gallbladder
- 5.2.3 Pathologic Conditions
- 5.2.3.1 Gallstones
- 5.2.3.2 Acute Cholecystitis
- 5.2.3.3 Acalculous Cholecystitis
- 5.2.3.4 Chronic Cholecystitis
- 5.2.3.5 Hyperplastic Cholecystosis
- 5.2.3.6 Gallbladder Neoplasms
- 5.3 Concluding Remarks
- References
- 6: Pathways for the Spread of Disease in the Abdomen and Pelvis
- 6.1 Introduction
- 6.2 Peritoneal Ligaments as Conduits for the Spread of Disease
- 6.2.1 Gastrohepatic and Hepatoduodenal Ligaments
- 6.2.2 Gastrosplenic and Splenorenal Ligaments
- 6.2.3 Gastrocolic Ligament and Transverse Mesocolon
- 6.3 Peritoneal Spaces as Pathways for the Spread of Disease.
- 6.3.1 Left Peritoneal Space
- 6.3.2 Right Peritoneal Space
- 6.4 Concluding Remarks
- References
- 7: Urogenital Pathologies in Children Revisited
- 7.1 Part I
- 7.1.1 Urinary Tract by Ultrasound: The BUK Approach
- 7.1.1.1 Introduction
- 7.1.1.2 Bladder
- 7.1.1.3 Ureters
- 7.1.1.4 Kidneys
- 7.1.1.5 Summary
- 7.2 Part II
- 7.2.1 Female Genital Tract
- 7.2.1.1 Normal Development
- 7.2.1.2 Uterus
- 7.2.1.3 Congenital Abnormalities
- 7.2.1.4 Ovaries
- 7.2.1.5 Ovarian Cysts and Other Lesions
- 7.2.1.6 Ovarian Torsion
- 7.2.1.7 Ovarian Neoplasm
- 7.3 Part III
- 7.3.1 Male Genital Tract
- 7.3.1.1 Normal Development
- 7.3.1.2 Congenital Abnormalities
- 7.3.1.3 Testicular Torsion
- 7.3.1.4 Inguinal Hernia
- References
- 8: Adnexal Diseases
- 8.1 Introduction
- 8.2 Imaging Modalities to Assess an Adnexal Mass
- 8.2.1 Ultrasound (US)
- 8.2.2 Magnetic Resonance Imaging (MRI)
- 8.2.3 Computed Tomography (CT)
- 8.2.4 Positron Emission Tomography/Computed Tomography (PET/CT)
- 8.3 Adnexal Masses on MRI
- 8.3.1 Benign Cystic Ovarian Masses
- 8.3.1.1 Ovarian Cysts
- 8.3.1.2 Endometriomas
- 8.3.1.3 Benign Teratomas (Mature Cystic Teratomas or Dermoid Cysts)
- 8.3.1.4 Cystadenomas
- 8.3.2 Benign Solid Ovarian Tumors
- 8.3.3 Borderline and Malignant Ovarian Tumors
- 8.4 Risk Stratification of Adnexal Masses Using the AdnexMR Score
- References
- 9: Adrenal Imaging
- 9.1 Introduction
- 9.1.1 Detection of Biochemically Active Adrenal Tumor
- 9.1.2 Staging Patients with Known Underlying Extra-Adrenal Malignancy
- 9.1.3 Evaluation of an Incidentally Discovered Adrenal Mass
- 9.2 Concluding Remarks
- References
- 10: Diseases of the Upper GI Tract
- 10.1 Nonneoplastic Conditions
- 10.1.1 Gastroesophageal Reflux Disease
- 10.1.2 Barrett's Esophagus.
- 10.1.3 Infectious Esophagitis
- 10.1.4 Eosinophilic Esophagitis
- 10.1.5 Drug-Induced Esophagitis
- 10.1.6 Erosive Gastritis
- 10.1.7 Helicobacter Pylori Gastritis
- 10.1.8 Gastric Ulcers
- 10.2 Neoplastic Conditions
- 10.2.1 Esophageal Cancer
- 10.2.2 Gastric Cancer
- 10.2.3 Gastric Lymphoma
- 10.2.4 Gastrointestinal Stromal Tumor (GIST)
- 10.2.5 Carcinoid Tumors
- References
- 11: Magnetic Resonance Imaging of the Prostate in the PI-RADS Era
- 11.1 Introduction
- 11.2 PI-RADS
- 11.2.1 Clinical Considerations
- 11.2.2 Technical Considerations
- 11.2.3 Assessment of Prostatic Lesions
- 11.2.4 Structured Reporting
- 11.3 Concluding Remarks
- Suggested Reading
- 12: Small Bowel Disease
- 12.1 Techniques (US, CTE, MRE)
- 12.2 Normal Anatomy
- 12.3 Pathology
- 12.3.1 Emergency
- 12.3.2 Inflammatory
- 12.3.2.1 Crohn's Disease (CD)
- 12.3.2.2 NSAID Enteropathy
- 12.3.2.3 Celiac Disease
- 12.3.3 Small Bowel Tumors
- 12.4 Concluding Remarks
- References
- 13: Emergency Radiology of the Abdomen and Pelvis: Imaging of the Non-traumatic and Traumatic Acute Abdomen
- 13.1 Imaging Techniques
- 13.1.1 General Considerations
- 13.1.2 CT
- 13.1.3 Ultrasound
- 13.1.4 Magnetic Resonance Imaging
- 13.2 Acute Pain in an Abdominal Quadrant
- 13.2.1 Right Upper Quadrant
- 13.2.2 Left Upper Quadrant
- 13.2.3 Right Lower Quadrant
- 13.2.4 Left Lower Quadrant
- 13.3 Gynecologic Disorders
- 13.4 Acute Abdomen with Diffuse Pain
- 13.4.1 Bowel Obstruction
- 13.4.2 Bowel Ischemia
- 13.4.3 Gastrointestinal Perforation
- 13.4.4 Acute Abdomen with Flank or Epigastric Pain
- 13.4.5 Urinary Colic
- 13.4.6 Acute Pancreatitis
- 13.5 Imaging of Abdominal and Pelvic Trauma
- 13.5.1 Blunt Abdominal Trauma
- 13.5.2 Imaging Techniques
- 13.5.3 Pneumoperitoneum.
- 13.5.4 Peritoneal Fluid.